Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

Date: March 1, 2016
Pages: 112
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD7B10DE619EN
Leaflet:

Download PDF Leaflet

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review
Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respiratory, cardiovascular and metabolic diseases and conditions, infection, inflammation, cancer, ophthalmic diseases, neurological problems, pain, tissue repair, gastrointestinal diseases, women’s health issues, orphan diseases and genitourinary infections, among others. The company also develops small molecules, biologics and vaccines. Pfizer sells prescription pharmaceutical products through wholesalers, besides selling them directly to retailers, hospitals, clinics, government agencies and pharmacies. It sells consumer healthcare products through pharmacies, retail chains, distributors and grocery and convenience stores. The company has operations across the Americas, Asia-Pacific, Europe and the Middle East and Africa. Pfizer is headquartered in New York, the US.

Pfizer Inc. Key Recent Developments

Feb 29, 2016: GNS Healthcare Study with Pfizer Reveals Discovery of Novel Clinical Risk Factors Driving Progression to Type 2 Diabetes and Prediabetes
Feb 22, 2016: The Breast Cancer Research Foundation Launches First-of-Its-Kind Breast Cancer Clinical Research Funding Model
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction
Feb 02, 2016: Pfizer Reports Fourth-Quarter And Full-Year 2015 Results Provides 2016 Financial Guidance
Jan 08, 2016: Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Pfizer Inc. - Key Facts
Pfizer Inc. - Key Employees
Pfizer Inc. - Key Employee Biographies
Pfizer Inc. - Major Products and Services
Pfizer Inc. - Pharmaceutical Pipeline Products Data
Pfizer Inc., Pipeline Products by Therapy Area
Pfizer Inc., Pipeline Products by Development Phase
Pfizer Inc. - History
Pfizer Inc. - Company Statement
Pfizer Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Pfizer Inc. - Business Description
Pfizer Inc. - Corporate Strategy
Pfizer Inc. - SWOT Analysis
SWOT Analysis - Overview
Pfizer Inc. - Strengths
Strength - Improved Performance of Innovative Products Business
Strength - Dominant Position
Strength - Emphasis on Research and Development Activities
Pfizer Inc. - Weaknesses
Weakness - Product Defects
Weakness - Discontinued Projects
Weakness - Declining Performance Global Established Pharmaceutical Division
Pfizer Inc. - Opportunities
Opportunity - Promising Product Pipeline
Opportunity - Significant Agreements and Collaboration
Opportunity - Strategic Acquisitions
Pfizer Inc. - Threats
Threat - Competitive Landscape
Threat - Government Regulations
Threat - Patent Expiry
Pfizer Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Pfizer Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 22, 2016: The Breast Cancer Research Foundation Launches First-of-Its-Kind Breast Cancer Clinical Research Funding Model
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction
Feb 02, 2016: Pfizer Reports Fourth-Quarter And Full-Year 2015 Results Provides 2016 Financial Guidance
Jan 08, 2016: Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations
Jan 04, 2016: FuelCell Energy Announces 5.6 Megawatt Fuel Cell Project With Pfizer
Jan 04, 2016: FuelCell Energy Announces 5.6 Megawatt Fuel Cell Project With Pfizer Inc.
Dec 07, 2015: Pfizer Awards Flagship OTC Product Manufacturing Contract To Catalent
Dec 04, 2015: Pfizer To Cease Operations At Granta Park R&D Facility In Cambridge
Nov 23, 2015: Morgan Lewis Serves as Lead U.S. Antitrust Counsel to Pfizer in Blockbuster Combination with Allergan
Nov 12, 2015: MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pfizer Inc., Key Facts
Pfizer Inc., Key Employees
Pfizer Inc., Key Employee Biographies
Pfizer Inc., Major Products and Services
Pfizer Inc., Number of Pipeline Products by Therapy Area
Pfizer Inc., Number of Pipeline Products by Development Stage
Pfizer Inc., Pipeline Products By Therapy Area and Development Phase
Pfizer Inc., History
Pfizer Inc., Other Locations
Pfizer Inc., Subsidiaries
Pfizer Inc., Affiliate
Pfizer Inc., Joint Venture
Pfizer Inc., Key Competitors
Pfizer Inc., Ratios based on current share price
Pfizer Inc., Annual Ratios
Pfizer Inc., Interim Ratios
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Pfizer Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Pfizer Inc., Pipeline Products by Therapy Area
Pfizer Inc., Pipeline Products by Development Phase
Pfizer Inc., Performance Chart (2011 - 2015)
Pfizer Inc., Ratio Charts
Pfizer Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Pfizer Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Johnson & Johnson
Actavis plc
Sanofi
Eli Lilly and Company
Merck & Co., Inc.
Bristol-Myers Squibb Company
Amgen Inc.
Synthetic Biologics, Inc.
Durata Therapeutics, Inc.
Mallinckrodt plc
Tesaro, Inc.
Cardiome Pharma Corp
NewLink Genetics Corporation
Bellus Health Inc.
Cempra, Inc.
Sophiris Bio, Inc.
SunHealth Solutions
Pernix Therapeutics Holdings, Inc.
Nutex Nyrt.
Karessa Pharma Holding AB
Capstone Therapeutics Corp.
Skip to top


Ask Your Question

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: